Seligman Municipal CA Quality A
100 Park Avenue 8th Floor New York NY 10017
Map
Phone: 800-221-7844
| Category: | Muni California Long | | Fund Family: | Seligman | | Net Assets: | 33.77M | | Year-to-Date Return: | -4.15% | | Yield: | 4.09% | | Morningstar Rating: |  | | Fund Inception Date: | 20-Nov-84 |
|
Thomas G. Moles
Lead Manager since
20-Nov-84 | | | Moles joined J. & W. Seligman & Company as a managing director in 1983. Previously, he spent eight years as a vice president at Marine Midland in the fixed-income and trust division, and has also worked for W. H. Morton & Company. Moles is a member of the Municipal Buyers Association and a member of the board of trustees of Wagner College. He has been awarded the Marine Corps Action Medal and the Vietnam-Navy Commendation Medal. |
| Min Initial Investment: | $1,000 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $1,000 | | Min Subsequent Investment: | $100 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $100 |
|
| |
| The investment seeks high income exempt from regular federal income taxes and from the personal income taxes of California consistent with preservation of capital and with consideration given to capital gain. The fund invests at least 80% of net assets in California municipal securities that are within the three highest ratings of Moody's Investors Service (Moody's) (Aaa, Aa, or A) or Standard & Poor's Ratings Services (S&P) (AAA, AA, or A) on the date of purchase. It generally invests in long-term municipal bonds. The fund is nondiversified. |
| Last Dividend
(17-Oct-08):
| 0.02 | | Last Cap Gain
(13-Nov-07):
| 0.05 | | Annual Holdings Turnover
| 5.00% | | Average for Category:
| 30.80% |
|
| Expense | SCTQX | Category
Avg | | Total Expense Ratio: | 0.92%
| 1.12% | | Max 12b1 Fee: | 0.10%
| N/A | | Max Front End Sales Load: | 4.75%
| 4.38% | | Max Deferred Sales Load: | 0.00%
| 2.62% | | 3 Yr Expense Projection*: |
$730 | $581 | | 5 Yr Expense Projection*: |
$936 | $834 | | 10 Yr Expense Projection*: |
$1,530 | $1,555 |
|
|
2.63% Nasdaq 0.00%
Profile
